(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.06%) $78.11
(5.26%) $2.14
(-0.04%) $2 308.60
(-0.52%) $26.69
(0.28%) $965.30
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
2.63% SEK 0.00390
Live Chart Being Loaded With Signals
Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease...
Stats | |
---|---|
Dzisiejszy wolumen | 299 948 |
Średni wolumen | 23.75M |
Kapitalizacja rynkowa | 10.57M |
EPS | SEK-0.00938 ( 2023-11-27 ) |
Następna data zysków | ( SEK0 ) 2024-05-21 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.0300 |
ATR14 | SEK0 (0.00%) |
Amniotics AB (publ) Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Amniotics AB (publ) Finanse
Annual | 2023 |
Przychody: | SEK0 |
Zysk brutto: | SEK-2.30M (0.00 %) |
EPS: | SEK-0.0676 |
FY | 2023 |
Przychody: | SEK0 |
Zysk brutto: | SEK-2.30M (0.00 %) |
EPS: | SEK-0.0676 |
FY | 2022 |
Przychody: | SEK0 |
Zysk brutto: | SEK-1.79M (0.00 %) |
EPS: | SEK-0.300 |
FY | 2021 |
Przychody: | SEK0.00 |
Zysk brutto: | SEK0.00 (0.00 %) |
EPS: | SEK-3.34 |
Financial Reports:
No articles found.
Amniotics AB (publ)
Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej